The American College of Cardiology (ACC) and Evidation Health are joining forces to develop Achievement for Heart Health. This first-of-its-kind health engagement experience will deliver evidence-based content, resources, and tools to thousands of individuals experiencing heart failure. This program, built on Evidation's Achievement platform, will make it easier than ever before for individuals to better understand and engage with their cardiovascular health outside clinic-based settings.
Digital health technologies have rapidly penetrated many aspects of consumers’ interactions with health care organizations, including how they make health care decisions and interact with their health plan. With so much information and technologies out there, it is not easy to build interventions or technologies easily adapted and effectively used to change lives. Behavioral science has barely scratched the surface of health care. The next decade will see health care begin to embrace behavioral science findings and methodologies, moving beyond the one-size-fits-all transactional delivery of care.
Blue Shield of California has announced three tobacco-cessation online providers to its popular Wellvolution platform, the largest Digital Therapeutics (DTX or PDT), and community network in the healthcare industry. With 49 million Americans using tobacco of some kind, the increased risk for multiple diseases has largely driven Blue Shield to add three new clinically proven health solutions for the 23,000+ members enrolled in Wellvolution.
Delaware-based health system ChristianaCare is expanding its innovative work to transform care through data and technology by adding Pear’s prescription digital therapeutics (PDTs or DTx) to treat substance use disorder and opioid use disorder. ChristianaCare will provide patients access to Boston-based Pear Therapeutics Inc.’s reSET and reSET-O PDTs through Project Recovery, ChristianaCare’s outpatient program for people with substance-use disorders.
Opear MD, a digital health membership-based app for on-demand house calls and telemedicine appointments, has announced two initiatives to increase healthcare accessibility and affordability during COVID-19.
In partnership with Truepill, LifeScan will add an e-commerce platform to its blood glucose monitoring mobile app, allowing users to buy testing supplies and wellness services from their homes. LifeScan will be Truepill's first partner in diabetes and chronic condition space. For LifeScan, this is a strategic move to expand its OneTouch brand offerings beyond diabetes testing supplies to innovative digital wellness offerings for diabetes and related health conditions, including weight loss, fitness, and hypertension.
Pear Therapeutics has announced collaboration with Wellpath Community Care Centers to bring its FDA-authorized digital therapeutics (DTx) to elevate the nation’s battle against the substance and opioid use crisis. Wellpath Community Care Centers can now offer Pear’s reSET® and reSET-O® products to provide same day, single centered comprehensive medical and behavioral services with 24/7 access to optimize clinician delivered medication-assisted treatment (MAT) for optimal outcomes.
Sharecare and the Boston University School of Public Health (SPH) have released their next-generation Community Well-Being Index (CWBI) state rankings report, constructing 10 years of well-being measurement through the integration of key social determinants of health data.
Amwell has filed to go public under the New York Stock Exchange symbol AMWL. Google Cloud's $100 million investment will be a concurrent private placement at the IPO price. The company didn't indicate a proposed size for the offering, nor did it give an anticipated price range, but it provided a placeholder amount of $100 million to calculate its registration fee. Morgan Stanley, Goldman Sachs & Co., LLC, Piper Sandler, UBS Investment Bank, Credit Suisse and Cowen Berenberg are listed as underwriters for the IPO.
